October 21, 2026

News, minutes after it breaks

Business
Latest
'Playing with fire': Knicks' Brown says he wouldn't have felt good about a win given playLeBron James' 76ers beat Knicks on NBA opening nightUK inflation jumps to 3.5% — cementing rate hike expectationsEmbiid 'all over the place' in 3-block opener, targets All-Defensive seasonDay: Ohio State planning to be without injured Sayin through postseasonFoden shines as Man City rout Athens 5-1 despite Haaland, Semenyo injuriesSixers rally in LeBron's debut, spoiling Knicks' championship celebrationQuinn says he addressed fourth-down throwaway with QB Daniels'Playing with fire': Knicks' Brown says he wouldn't have felt good about a win given playLeBron James' 76ers beat Knicks on NBA opening nightUK inflation jumps to 3.5% — cementing rate hike expectationsEmbiid 'all over the place' in 3-block opener, targets All-Defensive seasonDay: Ohio State planning to be without injured Sayin through postseasonFoden shines as Man City rout Athens 5-1 despite Haaland, Semenyo injuriesSixers rally in LeBron's debut, spoiling Knicks' championship celebrationQuinn says he addressed fourth-down throwaway with QB Daniels

Home  / Business

Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis

Business CNBC
Image: CNBC

Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.

CNBC reported this story. Read the full report on cnbc.com →

This is a short summary. CNBC wrote and published the full report.

Continue on cnbc.com →

More in Business

Leave a Reply

Your email address will not be published. Required fields are marked *